Truncated Orexin Peptides: Structure-Activity Relationship Studies

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Orexin receptors regulate critical physiological processes such as energy homeostasis, sleep-wake cycles, metabolism, and reward pathways.
• Developing selective ligands for orexin receptors is crucial for elucidating their underlying mechanisms of action.

Purpose of the Study:

• To investigate structure-activity relationships of orexin peptides.
• To identify truncated forms of orexin peptides with activity at the OX1 receptor.
• To determine the minimal sequence and key residues responsible for OX1 receptor agonism and selectivity.

Main Methods:

• Peptide truncation studies were performed to identify the shortest active sequence.
• Structure-activity relationship analyses, including alanine, D-amino acid, and proline scans, were conducted.
• Selectivity assays were used to compare activity at OX1 versus OX2 receptors.

Main Results:

• OXA (17-33) was identified as the shortest active peptide fragment, exhibiting 23-fold selectivity for OX1 over OX2 receptors.
• Specific amino acid residues, including Tyr17, Leu20, Asn25, and His26, were found to be critical for the agonist properties of OXA(17-33).
• The C-terminal conformation of orexin peptides appears to influence agonist activity and OX1 receptor selectivity.

Conclusions:

• The truncated peptide OXA (17-33) represents a potent and selective OX1 receptor agonist.
• Key residues and C-terminal conformation are essential determinants of orexin peptide activity and selectivity at the OX1 receptor.
• These findings provide valuable insights for the design of novel orexin receptor-targeting therapeutics.